Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

374 ARTÍCULOS , VIENDO DEL 271 AL 285

Treatment options and considerations for hypertensive patients to prevent dementia

Hernandorena I, Duron E, Vidal JS, Hanon O.

Expert Opin Pharmacother. 2017 Jul;18(10):989-1000. doi: 10.1080/14656566.2017.1333599. Epub 2017 May 29.

Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study

Koenig AM, Mechanic-Hamilton D, Xie SX, Combs MF, Cappola AR, Xie L, Detre JA, Wolk DA, Arnold SE.

Alzheimer Dis Assoc Disord. 2017 Apr-Jun;31(2):107-113. doi: 10.1097/WAD.0000000000000202.

Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk

Efthymiou AG, Goate AM.

Mol Neurodegener. 2017 May 26;12(1):43. doi: 10.1186/s13024-017-0184-x.

Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia

Viscogliosi G, Chiriac IM, Ettorre E.

J Am Med Dir Assoc. 2017 Sep 1;18(9):799-802. doi: 10.1016/j.jamda.2017.06.010. Epub 2017 Jul 21.

[A Review of Clinical Studies Investigating Patients with Alzheimer's Disease having Genetic Risk Factors]

Tanaka T, Ikeda M.

Brain Nerve. 2017 Jul;69(7):723-731. doi: 10.11477/mf.1416200813.

[Efficacy and tolerance of Memantine monotherapy and combination therapy with Reinhartdt And Sea Cucumber Capsule on agitation in moderate to severe Alzheimer disease]

Yu EY, Liao ZL, Tan YF, Qiu YJ, Zhu JP, Chen Y, Lin SS, Wu MH.

Zhonghua Yi Xue Za Zhi. 2017 Jul 18;97(27):2091-2094. doi: 10.3760/cma.j.issn.0376-2491.2017.27.003.

Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's disease

Prickaerts J, Heckman PRA, Blokland A.

Expert Opin Investig Drugs. 2017 Sep;26(9):1033-1048. doi: 10.1080/13543784.2017.1364360. Epub 2017 Aug 9.

Effectiveness of Florbetapir PET Imaging in Changing Patient Management

Pontecorvo MJ, Siderowf A, Dubois B, Doraiswamy PM, Frisoni GB, Grundman M, Nobili F, Sadowsky CH, Salloway S, Arora AK, Chevrette A, Deberdt W, Dell'Agnello G, Flitter M, Galante N, Lowrey MJ, Lu M, McGeehan A, Devous MD Sr, Mintun MA.

Dement Geriatr Cogn Disord. 2017;44(3-4):129-143. doi: 10.1159/000478007. Epub 2017 Aug 5.

Risk of Alzheimer's Disease Among Senior Medicare Beneficiaries Treated With Androgen Deprivation Therapy for Prostate Cancer

Baik SH, Kury FSP, McDonald CJ.

J Clin Oncol. 2017 Oct 20;35(30):3401-3409. doi: 10.1200/JCO.2017.72.6109. Epub 2017 Aug 25.

Cognitive frailty: a potential target for secondary prevention of dementia

Panza F, Lozupone M, Solfrizzi V, Stallone R, Bellomo A, Greco A, Daniele A, Seripa D, Logroscino G.

Expert Opin Drug Metab Toxicol. 2017 Oct;13(10):1023-1027. doi: 10.1080/17425255.2017.1372424. Epub 2017 Sep 5.

Phosphodiesterase-4B as a Therapeutic Target for Cognitive Impairment and Obesity-Related Metabolic Diseases

Clapcote SJ.

Adv Neurobiol. 2017;17:103-131. doi: 10.1007/978-3-319-58811-7_5.

Rheumatoid arthritis and risk for Alzheimer's disease: a systematic review and meta-analysis and a Mendelian Randomization study

Policicchio S, Ahmad AN, Powell JF, Proitsi P.

Sci Rep. 2017 Oct 9;7(1):12861. doi: 10.1038/s41598-017-13168-8.

Association between Antihypertensive Drug Use and the Incidence of Cognitive Decline and Dementia: A Meta-Analysis of Prospective Cohort Studies

Xu G, Bai F, Lin X, Wang Q, Wu Q, Sun S, Jiang C, Liang Q, Gao B.

Biomed Res Int. 2017;2017:4368474. doi: 10.1155/2017/4368474. Epub 2017 Sep 28.

Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team

Arnerić SP, Batrla-Utermann R, Beckett L, Bittner T, Blennow K, Carter L, Dean R, Engelborghs S, Genius J, Gordon MF, Hitchcock J, Kaplow J, Luthman J, Meibach R, Raunig D, Romero K, Samtani MN, Savage M, Shaw L, Stephenson D, Umek RM, Vanderstichele H, Willis B, Yule S.

J Alzheimers Dis. 2017;55(1):19-35. doi: 10.3233/JAD-160573.

Biomarkers for the Early Detection and Progression of Alzheimer's Disease

Counts SE, Ikonomovic MD, Mercado N, Vega IE, Mufson EJ.

Neurotherapeutics. 2017 Jan;14(1):35-53. doi: 10.1007/s13311-016-0481-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias